Nordic Nanovector ASA (OSE: NANO), a Norway-based biopharmaceutical company, has named Malene Brondberg as its new CFO effective 1 May it was reported on Monday.
The new CFO was vice president Investor Relations and Corporation Communications. Brondberg joined Nordic Nanovector in February 2018 and has more than 20 years' operational experience in the financial services sector. Her career has included global head of Research managing a team of 67 people and member of the executive committee of the Nordic investment bank, ABG Sundal Collier. Since 2011, she has worked as a management consultant within the financial sector, acting as an advisor in investor relations and funding, and has held various interim CEO, COO and head of Compliance/HR/Finance management positions.
In the new role, Brondberg will be responsible for the areas of Finance, Human Resources and Investor Relations.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business